One category · what the models named insteadAlternatives to Guardsquare DexGuard / iXGuard, as AI models named them
In the October 2026 Edition, 187 of the 252 answers collected in the one category where Guardsquare DexGuard / iXGuard holds a standing named it neither as a first choice nor as an alternative. These are the products those answers put first, category by category and buyer by buyer. The output is the models' output.
Application shielding
Seventy-one of the eighty-four answers did not name Guardsquare DexGuard / iXGuard; it was the first choice in one. The first choices in those seventy-one answers, twenty-two products in all, the eight most named:
Fifty-nine of the eighty-four answers did not name Guardsquare DexGuard / iXGuard; it was the first choice in eleven. The first choices in those fifty-nine answers, twenty-five products in all, the eight most named:
Fifty-seven of the eighty-four answers did not name Guardsquare DexGuard / iXGuard; it was the first choice in thirteen. The first choices in those fifty-seven answers, eighteen products in all, the eight most named:
How to read this
A category is asked six ways of each of fourteen models on behalf of each buyer segment, so a segment is eighty-four answers. An answer belongs on this page when the judge labeled Guardsquare DexGuard / iXGuard neither its first choice nor an alternative in it; the products listed are the first choices those answers made, counted once per answer. An answer that named nothing first, or named Guardsquare DexGuard / iXGuard only in passing, is in the denominator and adds to no product. The counts are not the category standing, which is on the category page with its share and rank; they are the same record read from Guardsquare DexGuard / iXGuard's side.
Every answer and every label behind these figures is in the record, sent on request. The output is the models' output; nothing here is a recommendation by the index, and a product named instead of Guardsquare DexGuard / iXGuard was named by a model, not endorsed by anyone.